Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Cancer
|
August 16, 2023
New era for myelofibrosis treatment with novel agents beyond Janus kinase-inhibitor monotherapy: Focus on clinical development of BCL-X<sub>L</sub> /BCL-2 inhibition with navitoclax
Naveen Pemmaraju, Jacqueline S Garcia, Andrew Perkins, et al.
Clinical Case Reports
|
May 3, 2024
The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report
Erin J Campbell, Yvonne Bonomo, Lisa Collins, et al.
Blood
|
June 12, 2014
Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factor
Xunde Wang, Laurel Mendelsohn, Heather Rogers, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
February 27, 2026
A pilot, parallel-group, blinded, placebo-controlled, randomise<b>D</b>, p<b>R</b>agmatic clinical trial investigating the <b>E</b>ffect of temazep<b>AM</b> on objective and subjective measures of sleep in critically ill patients (the DREAM trial)
Laurie Showler, Yasmine Ali Abdelhamid, Melissa J Ankravs, et al.
Pathology
|
April 24, 2022
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement
Anoop K Enjeti, Rishu Agarwal, Piers Blombery, et al.
Blood Neoplasia
|
June 2, 2025
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response
Naveen Pemmaraju, Tim C P Somervaille, Francesca Palandri, et al.
Future Oncology (London, England)
|
November 23, 2022
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis
Srdan Verstovsek, Haifa Kathrin Al-Ali, John Mascarenhas, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
October 16, 2023
Making good on the promise of genomics in healthcare: the NSW Health perspective
Deb Willcox, Ronald J A Trent, Nigel Lyons, et al.
Molecular and Cellular Biology
|
April 9, 2008
Targeted disruption of the basic Krüppel-like factor gene (Klf3) reveals a role in adipogenesis
Nancy Sue, Briony H A Jack, Sally A Eaton, et al.
Scientific Reports
|
June 29, 2016
High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22
Max Gulhane, Lydia Murray, Rohan Lourie, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Cancer
|
August 16, 2023
New era for myelofibrosis treatment with novel agents beyond Janus kinase-inhibitor monotherapy: Focus on clinical development of BCL-X<sub>L</sub> /BCL-2 inhibition with navitoclax
Naveen Pemmaraju, Jacqueline S Garcia, Andrew Perkins, et al.
Clinical Case Reports
|
May 3, 2024
The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report
Erin J Campbell, Yvonne Bonomo, Lisa Collins, et al.
Blood
|
June 12, 2014
Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factor
Xunde Wang, Laurel Mendelsohn, Heather Rogers, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
February 27, 2026
A pilot, parallel-group, blinded, placebo-controlled, randomise<b>D</b>, p<b>R</b>agmatic clinical trial investigating the <b>E</b>ffect of temazep<b>AM</b> on objective and subjective measures of sleep in critically ill patients (the DREAM trial)
Laurie Showler, Yasmine Ali Abdelhamid, Melissa J Ankravs, et al.
Pathology
|
April 24, 2022
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement
Anoop K Enjeti, Rishu Agarwal, Piers Blombery, et al.
Blood Neoplasia
|
June 2, 2025
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response
Naveen Pemmaraju, Tim C P Somervaille, Francesca Palandri, et al.
Future Oncology (London, England)
|
November 23, 2022
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis
Srdan Verstovsek, Haifa Kathrin Al-Ali, John Mascarenhas, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
October 16, 2023
Making good on the promise of genomics in healthcare: the NSW Health perspective
Deb Willcox, Ronald J A Trent, Nigel Lyons, et al.
Molecular and Cellular Biology
|
April 9, 2008
Targeted disruption of the basic Krüppel-like factor gene (Klf3) reveals a role in adipogenesis
Nancy Sue, Briony H A Jack, Sally A Eaton, et al.
Scientific Reports
|
June 29, 2016
High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22
Max Gulhane, Lydia Murray, Rohan Lourie, et al.
Page
of 5